Latest filing published 02 Jul 2019 for ZEVRA THERAPEUTICS, INC..
Insider track record
Danny L. Thompson: trading record in brief
Danny L. Thompson discloses dealings in Zevra Therapeutics, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 21 April 2015 to 30 June 2019.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 2 July 2019 with a share grant in Zevra Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Danny L. Thompson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,214 shares0Common StockSEC:0001437749-19-013394:0
- 8,873 shares0Common StockSEC:0001437749-19-009883:0
- 3,333 shares@ US$4.6515.8% of flowCommon StockSEC:0001437749-18-005591:0
- 2,026 shares@ US$7.6515.8% of flowCommon StockSEC:0001437749-18-005591:1
- 13,333 shares@ US$4.6568.4% of flowCommon StockSEC:0001209191-16-113477:0
- 7,373 sharesCommon StockSEC:0001209191-15-035360:0
- 91,687 sharesCommon StockSEC:0001209191-15-035360:1
7 of 7 declarations